Trial Profile
Randomised Double Blind Placebo Controlled Multicenter Study for Evaluation of Clinical Efficacy and Safety of Ingavirin 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2017
Price :
$35
*
At a glance
- Drugs Myelo 001 (Primary)
- Indications Influenza virus infections; Viral infections
- Focus Therapeutic Use
- Sponsors Valenta
- 19 May 2017 New trial record